13F HOLDINGS REPORT
SILVERARC CAPITAL MANAGEMENT, LLC
Quarter ended Q3 2025 · Filed November 12, 2025 · Accession 0001420506-25-003142
Total Value
$741.6M
Positions
82
Other Managers
1
Confidential Omitted
No
Holdings (82)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | ABIVAX SA | AAVXF | 539,704 | $45.8M | 6.18% |
| 2 | RHYTHM PHARMACEUTICALS INC | RYTM | 369,996 | $37.4M | 5.04% |
| 3 | AVIDITY BIOSCIENCES INC | 05370A108 | 844,633 | $36.8M | 4.96% |
| 4 | NUVALENT INC | NUVL | 372,300 | $32.2M | 4.34% |
| 5 | UROGEN PHARMA LTD | URGN | 1,577,283 | $31.5M | 4.24% |
| 6 | AKERO THERAPEUTICS INC | 00973Y108 | 643,636 | $30.6M | 4.12% |
| 7 | INSMED INC | INSM | 206,648 | $29.8M | 4.01% |
| 8 | DIANTHUS THERAPEUTICS INC | DNTH | 674,966 | $26.6M | 3.58% |
| 9 | UNIQURE NV | QURE | 455,000 | $26.6M | 3.58% |
| 10 | CG ONCOLOGY INC | CGON | 638,346 | $25.7M | 3.47% |
| 11 | UNITED THERAPEUTICS CORP DEL | 91307C952 | 59,900 | $25.1M | 3.39% |
| 12 | ORIC PHARMACEUTICALS INC | ORIC | 1,948,808 | $23.4M | 3.15% |
| 13 | CIDARA THERAPEUTICS INC | 171757206 | 220,902 | $21.2M | 2.85% |
| 14 | FRACTYL HEALTH INC | GUTS | 10,600,000 | $16.9M | 2.27% |
| 15 | KALVISTA PHARMACEUTICALS INC | KALV | 1,363,378 | $16.6M | 2.24% |
| 16 | KODIAK SCIENCES INC | KOD | 1,000,000 | $16.4M | 2.21% |
| 17 | ULTRAGENYX PHARMACEUTICAL IN | RARE | 528,200 | $15.9M | 2.14% |
| 18 | GOSSAMER BIO INC | GOSS | 4,779,082 | $12.6M | 1.69% |
| 19 | COGENT BIOSCIENCES INC | COGT | 815,075 | $11.7M | 1.58% |
| 20 | CYTOKINETICS INC | CYTK | 211,000 | $11.6M | 1.56% |
| 21 | VAXCYTE INC | PCVX | 314,339 | $11.3M | 1.53% |
| 22 | BIOGEN INC | BIIB | 80,419 | $11.3M | 1.52% |
| 23 | ASCENDIS PHARMA A/S | ASND | 53,554 | $10.6M | 1.44% |
| 24 | COMPASS THERAPEUTICS INC | CMPX | 2,833,988 | $9.9M | 1.34% |
| 25 | AMYLYX PHARMACEUTICALS INC | AMLX | 700,000 | $9.5M | 1.28% |
| 26 | VERASTEM INC | VSTM | 1,042,757 | $9.2M | 1.24% |
| 27 | AVALO THERAPEUTICS INC | AVTX | 720,922 | $9.2M | 1.24% |
| 28 | OLEMA PHARMACEUTICALS INC | OLMA | 933,541 | $9.1M | 1.23% |
| 29 | CELLDEX THERAPEUTICS INC NEW | CLDX | 348,922 | $9.0M | 1.22% |
| 30 | SCHOLAR ROCK HLDG CORP | SRRK | 233,920 | $8.7M | 1.17% |
| 31 | VERACYTE INC | VCYT | 235,791 | $8.1M | 1.09% |
| 32 | SYNDAX PHARMACEUTICALS INC | SNDX | 463,708 | $7.1M | 0.96% |
| 33 | RAPPORT THERAPEUTICS INC | RAPP | 203,946 | $6.1M | 0.82% |
| 34 | VIRIDIAN THERAPEUTICS INC | VRDN | 259,509 | $5.6M | 0.76% |
| 35 | ALKERMES PLC | ALKS | 180,513 | $5.4M | 0.73% |
| 36 | TREVI THERAPEUTICS INC | TRVI | 588,789 | $5.4M | 0.73% |
| 37 | BRIDGEBIO ONCOLOGY THERAPEUT | BBOT | 457,414 | $5.3M | 0.71% |
| 38 | ABEONA THERAPEUTICS INC | ABEO | 994,754 | $5.3M | 0.71% |
| 39 | LEXEO THERAPEUTICS INC | LXEO | 778,611 | $5.2M | 0.70% |
| 40 | COGENT BIOSCIENCES INC | COGT | 360,000 | $5.2M | 0.70% |
| 41 | MONTE ROSA THERAPEUTICS INC | GLUE | 694,942 | $5.1M | 0.69% |
| 42 | COMPUGEN LTD | CGEN | 3,311,165 | $4.9M | 0.66% |
| 43 | PHARVARIS N V | PHVS | 183,903 | $4.6M | 0.62% |
| 44 | CELCUITY INC | CELC | 88,686 | $4.4M | 0.59% |
| 45 | CERUS CORP | CERS | 2,715,786 | $4.3M | 0.58% |
| 46 | C4 THERAPEUTICS INC | CCCC | 1,897,383 | $4.2M | 0.57% |
| 47 | TELA BIO INC | TELA | 2,782,923 | $4.1M | 0.56% |
| 48 | AARDVARK THERAPEUTICS INC | AARD | 306,912 | $4.1M | 0.55% |
| 49 | BICARA THERAPEUTICS INC | BCAX | 250,606 | $4.0M | 0.53% |
| 50 | BENITEC BIOPHARMA INC | BNTC | 276,267 | $3.9M | 0.52% |
| 51 | KINIKSA PHARMACEUTICALS INTL | G52694109 | 88,910 | $3.5M | 0.47% |
| 52 | CENTESSA PHARMACEUTICALS PLC | CNTA | 141,238 | $3.4M | 0.46% |
| 53 | EYEPOINT PHARMACEUTICALS INC | EYPT | 230,837 | $3.3M | 0.44% |
| 54 | SIONNA THERAPEUTICS INC | SION | 108,801 | $3.2M | 0.43% |
| 55 | ZURA BIO LTD | ZURA | 720,452 | $3.1M | 0.42% |
| 56 | MINERALYS THERAPEUTICS INC | MLYS | 80,000 | $3.0M | 0.41% |
| 57 | ERASCA INC | ERAS | 1,368,075 | $3.0M | 0.40% |
| 58 | PRAXIS PRECISION MEDICINES I | PRAX | 51,210 | $2.7M | 0.37% |
| 59 | ELUTIA INC | ELUT | 2,850,987 | $2.5M | 0.34% |
| 60 | DELCATH SYS INC | DCTH | 203,386 | $2.2M | 0.29% |
| 61 | CRINETICS PHARMACEUTICALS IN | CRNX | 50,000 | $2.1M | 0.28% |
| 62 | CAMP4 THERAPEUTICS CORP | CAMP | 653,594 | $2.0M | 0.26% |
| 63 | CONTINEUM THERAPEUTICS INC | CTNM | 166,161 | $2.0M | 0.26% |
| 64 | DYNE THERAPEUTICS INC | DYN | 100,000 | $1.3M | 0.17% |
| 65 | LB PHARMACEUTICALS INC | LBRX | 70,000 | $1.1M | 0.15% |
| 66 | CAPRICOR THERAPEUTICS INC | CAPR | 144,700 | $1.0M | 0.14% |
| 67 | MERSANA THERAPEUTICS INC | 59045L205 | 133,636 | $1.0M | 0.14% |
| 68 | RADIOPHARM THERANOSTICS LTD | RDPTF | 187,406 | $1.0M | 0.14% |
| 69 | ATYR PHARMA INC | ATYR | 1,250,000 | $901,250 | 0.12% |
| 70 | IMMUNOVANT INC | IMVT | 50,000 | $806,000 | 0.11% |
| 71 | ARCTURUS THERAPEUTICS HLDGS | ARCT | 42,000 | $774,060 | 0.10% |
| 72 | SYNDAX PHARMACEUTICALS INC | SNDX | 50,000 | $769,500 | 0.10% |
| 73 | ULTRAGENYX PHARMACEUTICAL IN | RARE | 25,000 | $752,000 | 0.10% |
| 74 | MOONLAKE IMMUNOTHERAPEUTICS | MLTX | 65,000 | $466,050 | 0.06% |
| 75 | MODULAR MED INC | MODD | 639,531 | $447,544 | 0.06% |
| 76 | BIODESIX INC | BDSX | 49,607 | $374,533 | 0.05% |
| 77 | MBX BIOSCIENCES INC | MBX | 15,000 | $262,500 | 0.04% |
| 78 | ENLIVEN THERAPEUTICS INC | ELVN | 10,675 | $218,517 | 0.03% |
| 79 | MOONLAKE IMMUNOTHERAPEUTICS | MLTX | 30,000 | $215,100 | 0.03% |
| 80 | ARCTURUS THERAPEUTICS HLDGS | ARCT | 3,445 | $63,491 | 0.01% |
| 81 | NEKTAR THERAPEUTICS | NKTR | 365 | $20,769 | 0.00% |
| 82 | ROCKET PHARMACEUTICALS INC | RCKTW | 104,828 | $4,109 | 0.00% |